Session Details
[29P]Medicinal Chemistry, bioactive materials 5
Sat. Mar 29, 2025 8:30 AM - 3:00 PM JST
Sat. Mar 29, 2025 11:30 PM - 6:00 AM UTC
Sat. Mar 29, 2025 11:30 PM - 6:00 AM UTC
Poster (MARINE MESSE FUKUOKA Hall B: Exhibition Room [1F])
[29P-018S]Development of a novel tryptophan derivative and its analytical chemical propertities(Ⅱ)
○Honoka Fujimoto1, Reika Aoki1, Tatsuya Sakamoto1, Mayu Onozato1, Takeshi Fukushima1 (1. Pharm Sci., Toho Univ.)
[29P-019S]Synthesis and cytotoxicity evaluation of novel makaluvamine derivatives
○Yuiko Yasuda1, Yo Kiichi1, Anna Kitano1, Naoyuki Kotoku1 (1. Coll. Pharm. Sci., Ritsumeikan Univ.)
[29P-020]Development of amphipathic helical peptides containing unnatural amino acids for plasmid DNA derivery
Motoki Naka1, ○Tomohiro Umeno1, Mika Shibuya2, Yuto Yamaberi2, Atsushi Ueda2, Masakazu Tanaka2, Hiroyasu Takemoto1, Makoto Oba1 (1. Grad. Sch. Med. Sci., Kyoto Prefectural Univ. of Medicine, 2. Grad. Sch. Biomed. Sci., Nagasaki Univ.)
[29P-021]Optimization Study of Automated Sample Preparation For Multi-attribute Method
○Keisuke Fukazawa1, Sachiko Shindo1, Makiko Ichiki1, Tatsuya Ezaki1 (1. Nihon Waters K.K.)
[29P-022]Exploring of antibodies with α-synuclein hydrolyzing activity for treatment of synucleinopathy
○Hiroaki Taguchi1, Hiroki Yokokura1, Naoya Hatsuyama1, Arisa Matsuo1, Satoshi Nakagawa1, Ryouta Isshiki1, Emi Hifumi2, Taizou Uda3 (1. Suzuka University of Medical Science, 2. Res. Manag., Ohita Univ., 3. Ins. Sys., Inf. Tech. and Nanotech.)
[29P-023S]Improved synthetic route of anti-breast cancer peptide having amide-type staple linkage
○Daiki Sasagawa1, Chiho Shinozaki2, Masaya Denda3, Tetsuro Yoshimaru4, Toyomasa Katagiri4, Akira Otaka3 (1. Sch. Pharm. Sci., Tokushima Univ., 2. Grad. Pharm. Sci., Tokushima Univ., 3. Grad. Sci. Biomed. Sci., Tokushima Univ., 4. NIBIOHN)
[29P-024]Purification of In Vitro Transcription mRNA by Ion-Pair HPLC Using Macroporous Resin: Removal of Double-Stranded RNA Impurities
○Michelle Rakotondravao1, Yuki Higuchi1, Akinari Awatani1,2, Takashi Sekida2, Taeko Nakajima1 (1. YMC CO., LTD., 2. VLP Therapeutics Japan Inc.)
[29P-025S]Chemical Synthesis and Evaluation of Mirror-Image VHHs against VEGF
○Manrei Yonemura1, Keisuke Aoki1,2, Kayuu Maeda3, Naoya Iwamoto1,2, Motohiro Nonaka3, Shinya Oishi1,2 (1. Kyoto Pharm. Univ., 2. Grad. Sch. Pharm. Sci., Kyoto Univ., 3. Grad. Sch. Med., Kyoto Univ.)
[29P-026S]Development of senescent cell-selective peptides by on-bead cell screening
○Riko Oyama1, Sota Yamada1, Kento Takaya2, Kazuo Kishi2, Kenjiro Hanaoka1 (1. Faculty of Pharmacy, Keio University, 2. School of Medicine, Keio University)
[29P-027]Automatic Optimization of Gradient Conditions by AI Algorithm on Synthetic Peptide and Related Impurities
○Shinichi Fujisaki1, Hidetoshi Terada1 (1. Shimadzu Corporation)
[29P-028]Purity Confirmation of Synthetic Peptides - Determination of Counter Ions of Poorly Water-Soluble Peptides -
○Ayano Tanabe1, Hiroko Yamamoto2, Tomoko Kuriki1, Hidetoshi Terada1 (1. Shimadzu Corporation, 2. Shimadzu Techno Research)
[29P-029]Streamlining of Synthetic Peptides Purification by Automated Scale-Up from Analytical to Preparative
○Yusuke Masuda1, Tomoko Kuriki1, Hidetoshi Terada1, Ryo Kubota1 (1. Shimadzu Corporation)
[29P-030]Confirmation of Molecular Weight and Amino Acid Sequence of Synthetic Peptides using MALDI-TOF MS
○Kumiko Yamaguchi1, Tomoko Kuriki1, Hidetoshi Terada1, Ryo Yamaguchi1 (1. SCOE Analytical & Measuring Instruments Div. Shimadzu Corp.)
[29P-031]Primary Structure Analyses of Peptides Containing Modified Amino Acids And Cyclic Peptide with Disulfide Bond
○Tomoko Kuriki1, Kumiko Yamaguchi1, Hidetoshi Terada1 (1. SCOE Analytical & Measuring Instruments Div. Shimadzu Corp.)